Federal regulation of CBD products briefly became the focus of a Senate confirmation hearing Wednesday, as senators questioned Trump’s nominee to lead the Food and Drug Administration. One lawmaker described his own experience with the unregulated market for the hemp-derived product.
“I have football knees” Sen. Pat Roberts told Stephen Hahn, the nominee, before describing his “personal interest” in cannabidiol regulations.